These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 8432604)

  • 41. Trying to See the Forest through the Trees: Deciphering the Nature of Memory Immunity to
    Orme IM; Henao-Tamayo MI
    Front Immunol; 2018; 9():461. PubMed ID: 29568298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Specificity of T cells in human resistance to Mycobacterium tuberculosis infection.
    Mendez-Samperio P; Gonzalez-Garcia L; Pineda-Fragoso PR; Ramos-Sanchez E
    Cell Immunol; 1995 May; 162(2):194-201. PubMed ID: 7743546
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vaccination with plasmid DNA encoding mycobacterial antigen 85A stimulates a CD4+ and CD8+ T-cell epitopic repertoire broader than that stimulated by Mycobacterium tuberculosis H37Rv infection.
    Denis O; Tanghe A; Palfliet K; Jurion F; van den Berg TP; Vanonckelen A; Ooms J; Saman E; Ulmer JB; Content J; Huygen K
    Infect Immun; 1998 Apr; 66(4):1527-33. PubMed ID: 9529077
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.
    Flynn JL; Goldstein MM; Triebold KJ; Koller B; Bloom BR
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12013-7. PubMed ID: 1465432
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative analysis of B- and T-cell epitopes of Mycobacterium leprae and Mycobacterium tuberculosis culture filtrate protein 10.
    Spencer JS; Kim HJ; Marques AM; Gonzalez-Juarerro M; Lima MC; Vissa VD; Truman RW; Gennaro ML; Cho SN; Cole ST; Brennan PJ
    Infect Immun; 2004 Jun; 72(6):3161-70. PubMed ID: 15155617
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunological crossreactivity of the Mycobacterium leprae CFP-10 with its homologue in Mycobacterium tuberculosis.
    Geluk A; van Meijgaarden KE; Franken KL; Wieles B; Arend SM; Faber WR; Naafs B; Ottenhoff TH
    Scand J Immunol; 2004 Jan; 59(1):66-70. PubMed ID: 14723623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prolonged intervals during Mycobacterium tuberculosis subunit vaccine boosting contributes to eliciting immunity mediated by central memory-like T cells.
    Bai C; He J; Niu H; Hu L; Luo Y; Liu X; Peng L; Zhu B
    Tuberculosis (Edinb); 2018 May; 110():104-111. PubMed ID: 29779765
    [TBL] [Abstract][Full Text] [Related]  

  • 48. How B cells shape the immune response against Mycobacterium tuberculosis.
    Maglione PJ; Chan J
    Eur J Immunol; 2009 Mar; 39(3):676-86. PubMed ID: 19283721
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mycobacterium tuberculosis defective in phthiocerol dimycocerosate translocation provides greater protective immunity against tuberculosis than the existing bacille Calmette-Guérin vaccine.
    Pinto R; Saunders BM; Camacho LR; Britton WJ; Gicquel B; Triccas JA
    J Infect Dis; 2004 Jan; 189(1):105-12. PubMed ID: 14702160
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
    Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
    Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Construction and evaluation of a multistage Mycobacterium tuberculosis subunit vaccine candidate Mtb10.4-HspX.
    Niu H; Hu L; Li Q; Da Z; Wang B; Tang K; Xin Q; Yu H; Zhang Y; Wang Y; Ma X; Zhu B
    Vaccine; 2011 Nov; 29(51):9451-8. PubMed ID: 22024175
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Influence of phthiocerol dimycocerosate on CD4(+) T cell priming and persistence during Mycobacterium tuberculosis infection.
    Pinto R; Nambiar JK; Leotta L; Counoupas C; Britton WJ; Triccas JA
    Tuberculosis (Edinb); 2016 Jul; 99():25-30. PubMed ID: 27450001
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Induction of Mycobacterium tuberculosis-specific primary and secondary T-cell responses in interleukin-15-deficient mice.
    Lazarevic V; Yankura DJ; DiVito SJ; Flynn JL
    Infect Immun; 2005 May; 73(5):2910-22. PubMed ID: 15845497
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Purification and characterization of a low-molecular-mass T-cell antigen secreted by Mycobacterium tuberculosis.
    Sørensen AL; Nagai S; Houen G; Andersen P; Andersen AB
    Infect Immun; 1995 May; 63(5):1710-7. PubMed ID: 7729876
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Longitudinal analysis of Mycobacterium tuberculosis 19-kDa antigen-specific T cells in patients with pulmonary tuberculosis: association with disease activity and cross-reactivity to a peptide from HIVenv gp120.
    Höhn H; Kortsik C; Tully G; Nilges K; Necker A; Freitag K; Neukirch C; Galle P; Löhr H; Maeurer MJ
    Eur J Immunol; 2003 Jun; 33(6):1613-23. PubMed ID: 12778479
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mycobacterium tuberculosis-specific cellular immune profiles suggest bacillary persistence decades after spontaneous cure in untreated tuberculosis.
    Millington KA; Gooding S; Hinks TS; Reynolds DJ; Lalvani A
    J Infect Dis; 2010 Dec; 202(11):1685-9. PubMed ID: 20958211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Arabinosylated lipoarabinomannan modulates the impaired cell mediated immune response in Mycobacterium tuberculosis H37Rv infected C57BL/6 mice.
    Majumder N; Bhattacharjee S; Dey R; Bhattacharyya Majumdar S; Pal NK; Majumdar S
    Microbes Infect; 2008 Apr; 10(4):349-57. PubMed ID: 18417403
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating, Mycobacterium tuberculosis-specific lymphocytes from PPD skin test-negative patients with tuberculosis do not secrete interferon-gamma (IFN-gamma) and lack the cutaneous lymphocyte antigen skin-selective homing receptor.
    Magnani ZI; Confetti C; Besozzi G; Codecasa LR; Panina-Bordignon P; Lang R; Rossi GA; Pardi R; Burastero SE
    Clin Exp Immunol; 2000 Jan; 119(1):99-106. PubMed ID: 10606970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
    van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
    Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection.
    Orme IM; Roberts AD; Griffin JP; Abrams JS
    J Immunol; 1993 Jul; 151(1):518-25. PubMed ID: 8100846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.